Clinical Trials Directory

Trials / Completed

CompletedNCT07303036

Chronobiological Determinants of Gut Microbiome

Chronobiological Determinants of Gut Microbiome: The Effects of Meal Timing and Eating Frequency

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
26 Years – 60 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to examine how the number of daily eating occasions and the timing of energy intake influence gut microbiome composition in both morbidly obese and non-obese individuals. The analysis is based on baseline data from a case-control study involving 11 non-obese and 23 morbidly obese adults. Participants were excluded if they were younger than 19 or older than 65 years, had an acute or chronic inflammatory condition, had been diagnosed with an infectious disease, cancer, or alcohol dependence, or had used antibiotics within the three months prior to screening.

Detailed description

This study aimed to investigate how the number of daily eating occasions and the timing of energy intake influence gut microbiome composition in morbidly obese and non-obese adults. This case-control study examined the gut microbiota of 23 morbidly obese individuals (BMI \> 40 kg/m²) and 11 non-obese individuals (BMI \< 30 kg/m²). Dietary intake was assessed using 24-hour dietary recall records. From these data, the number of meals, total daily energy intake, and the proportion of energy consumed within specific time intervals (06:00-13:00, 13:00-20:00, and 20:00-06:00) were calculated. Energy intake occurring after 20:00 was defined as nighttime eating. Participant eligibility required individuals to be between 19 and 65 years of age, free from acute or chronic inflammatory diseases, and without diagnoses of infectious diseases, cancer, or alcohol addiction. Additionally, participants were excluded if they had taken antibiotics within the three months preceding the screening.

Conditions

Timeline

Start date
2016-10-20
Primary completion
2018-01-01
Completion
2019-06-21
First posted
2025-12-24
Last updated
2025-12-24

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07303036. Inclusion in this directory is not an endorsement.